Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ipratropium Bromide Versus Short Acting Beta‐2 Agonists for Stable Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436194/all/Ipratropium_bromide_versus_short_acting_beta‐2_agonists_for_stable_chronic_obstructive_pulmonary_disease. Accessed 10 October 2024.
Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436194/all/Ipratropium_bromide_versus_short_acting_beta‐2_agonists_for_stable_chronic_obstructive_pulmonary_disease. Accessed October 10, 2024.
Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436194/all/Ipratropium_bromide_versus_short_acting_beta‐2_agonists_for_stable_chronic_obstructive_pulmonary_disease
Ipratropium Bromide Versus Short Acting Beta‐2 Agonists for Stable Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. [cited 2024 October 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436194/all/Ipratropium_bromide_versus_short_acting_beta‐2_agonists_for_stable_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease
ID - 436194
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436194/all/Ipratropium_bromide_versus_short_acting_beta‐2_agonists_for_stable_chronic_obstructive_pulmonary_disease
DB - Evidence Central
DP - Unbound Medicine
ER -